Avacta Group: Funding, Investors & Team (Sep 2026)
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. It is engaged in the research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology. The Company has two segments: Analytical and Animal Health. The Analytical segment provides tools and contract services for early stage protein characterisation and analysis for biopharmaceutical drug developers. The Animal Health provides tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. The Company’s subsidiaries include Avacta Limited, Avacta Analytical Limited, Oriental Fine Foods Limited, Avacta Health Limited, TheraGenetics Limited and TheraGenetics Inc. ###Readybuy Plc acquires Avacta Ltd in a reverse merger and changed name to Avacta Group Plc in 2004. Readybuy was founded in 2003.###
Avacta Group has raised $13.3M across 1 funding round on record, the most recent an undisclosed round of $13.3M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Avacta Group Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Avacta Group Funding Rounds
Avacta Group Founders and Leadership Team
Contact details for the Avacta Group team: 1 has a LinkedIn profile.
Start 14-day free trial →Avacta Group Funding Compared to Other Biotechnology Startups
Avacta Group's latest round of $13.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Avacta Group in Biotechnology and Wetherby
Companies Similar to Avacta Group
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Avacta Group Funding FAQs
What does Avacta Group do?
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. It is engaged in the research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology. The Company has two segments: Analytical and Animal Health. The Analytical segment provides tools and contract services for early stage protein characterisation and analysis for biopharmaceutical drug developers. The Animal Health provides tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. The Company’s subsidiaries include Avacta Limited, Avacta Analytical Limited, Oriental Fine Foods Limited, Avacta Health Limited, TheraGenetics Limited and TheraGenetics Inc. ###Readybuy Plc acquires Avacta Ltd in a reverse merger and changed name to Avacta Group Plc in 2004. Readybuy was founded in 2003.###
How much funding has Avacta Group raised?
Avacta Group has raised $13.3M across 1 round on record. The most recent is an undisclosed round of $13.3M announced in Mar 2026.
When did Avacta Group last raise funding?
Avacta Group's most recent funding round on record is an undisclosed round of $13.3M, announced in Mar 2026.
Who founded Avacta Group?
FundedIQ lists Christina Coughlin (Founder) at Avacta Group.
Where is Avacta Group headquartered?
Avacta Group is based in Wetherby, York, United Kingdom.
How many employees does Avacta Group have?
Avacta Group is in the 51-100 employee band.
How does Avacta Group's funding compare to other Biotechnology startups?
Avacta Group's latest round of $13.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Avacta Group Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avacta Group is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.